{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:40:39Z","timestamp":1786549239011,"version":"build-2736575974"},"reference-count":126,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Ovarian cancer remains a leading cause of gynecologic cancer death worldwide, largely due to late diagnosis, frequent recurrence, and metastatic tendencies. Thrombosis is a common and life-threatening complication in these patients, contributing to poor prognosis and therapy resistance. Emerging evidence highlights a mechanistic link between tumor-derived extracellular vesicles and thrombotic events \u2013 particularly podoplanin-positive small extracellular vesicles (PDPN\u207a sEVs). Secreted by PDPN-expressing ovarian tumor cells, these vesicles act as biologically active messengers that circulate systemically. A central mechanism involves the binding of PDPN\u207a sEVs to C-type lectin-like receptor 2 (CLEC-2) on platelets, inducing platelet activation, aggregation, and the release of pro-inflammatory mediators. This interaction creates a hypercoagulable and pro-inflammatory microenvironment. Beyond coagulation, PDPN\u207a sEVs promote cancer aggressiveness by enhancing cancer stem cell plasticity, driving epithelial-to-mesenchymal transition, and facilitating immune evasion \u2013 hallmarks of metastasis and chemoresistance. This dual activity establishes a thromboinflammatory tumor niche that accelerates disease progression while undermining treatment efficacy. The ability of PDPN\u207a sEVs to circulate in ascitic fluid and peripheral blood positions them as promising candidates for liquid biopsy\u2013based diagnostics. Furthermore, targeting the PDPN\u2013CLEC\u20112 axis or disrupting sEV biogenesis offers a novel therapeutic strategy to curb both thrombosis and metastatic spread. In conclusion, PDPN\u207a sEVs represent a critical molecular link between coagulation and cancer progression, offering valuable diagnostic, prognostic, and therapeutic potential for improving outcomes in ovarian cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000005293","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:01:24Z","timestamp":1784624484000},"page":"5204-5215","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Podoplanin-positive extracellular vesicles in ovarian cancer: linking thrombosis, platelet crosstalk, and cancer stemness \u2013 a narrative review"],"prefix":"10.1097","volume":"88","author":[{"given":"Shreya Singh","family":"Beniwal","sequence":"first","affiliation":[{"name":"Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rovena","family":"Tali","sequence":"additional","affiliation":[{"name":"University of Medicine, Tirana, Albania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8464-6849","authenticated-orcid":false,"given":"Samid Soeb","family":"Munshi","sequence":"additional","affiliation":[{"name":"B.J. Medical College, Ahmedabad, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4620-2042","authenticated-orcid":false,"given":"Yash Satish","family":"Caroicar","sequence":"additional","affiliation":[{"name":"Goa Medical Collegeand Hospital, Goa University, Goa, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5668-5643","authenticated-orcid":false,"family":"Zainab","sequence":"additional","affiliation":[{"name":"Dr. VRK Women\u2019s Medical College, Moinabad, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0960-6402","authenticated-orcid":false,"given":"Dina","family":"Mohamed","sequence":"additional","affiliation":[{"name":"University of Medical Sciences and Technology, Kigali, Rwanda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9426-6019","authenticated-orcid":false,"given":"Aala","family":"Alhamsa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Khartoum, Khartoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-5840","authenticated-orcid":false,"given":"Yujin","family":"Jeong","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai\/Elmhurst Hospital Center, Elmhurst, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2999-9604","authenticated-orcid":false,"given":"Prashasti","family":"Dahiya","sequence":"additional","affiliation":[{"name":"ESIC Medical College and Hospital, Faridabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0798-890X","authenticated-orcid":false,"given":"Rafael Everton Assun\u00e7\u00e3o","family":"Ribeiro da Costa","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas (UNICAMP), Campus Cidade Universit\u00e1ria Zeferino Vaz, Campinas, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9376-2939","authenticated-orcid":false,"given":"Chimuka","family":"Mwaanga","sequence":"additional","affiliation":[{"name":"Texila American University Zambia, Lusaka, Zambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarushi","family":"Mishra","sequence":"additional","affiliation":[{"name":"Lvivs\u2019kyj naciona\u013e\u2019nyj medychnyj universytet imeni Danyla Halyc\u2019koho, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"R1-20260812","first-page":"209\u201349","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA a Cancer J Clin"},{"key":"R2-20260812","doi-asserted-by":"crossref","first-page":"245.e1\u2013245.e15","DOI":"10.1016\/j.ajog.2019.04.035","article-title":"Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse","volume":"221","author":"Hollis","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20260812","article-title":"Genomic and clinical insights into ovarian cancer:subtype-specific alterations and predictors of metastasis and relapse","volume":"16","author":"Cheng","year":"2025","journal-title":"Discov Oncol"},{"key":"R4-20260812","first-page":"1021\u201327","article-title":"Statement by the kommission OVAR of the AGO: the new FIGO and WHO classifications of ovarian, fallopian tube and primary peritoneal cancer","volume":"75","author":"Meinhold-heerlein","year":"2015","journal-title":"Geburtshilfe Und Frauenheilkunde"},{"key":"R5-20260812","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/cancers11070907","article-title":"Ovarian cancer stemness: biological and clinical implications for metastasis and chemotherapy resistance","volume":"11","author":"Motohara","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R6-20260812","first-page":"117\u201326","article-title":"Ovarian cancer stem cells and their role in drug resistance","volume":"106","author":"Pieterse","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"R7-20260812","doi-asserted-by":"crossref","first-page":"1118\u201329","DOI":"10.21037\/gs-20-325","article-title":"Secondary and tertiary ovarian cancer recurrence: what is the best management?","volume":"9","author":"Garzon","year":"2020","journal-title":"Gland Surg"},{"key":"R8-20260812","doi-asserted-by":"crossref","first-page":"378\u201384","DOI":"10.1053\/j.seminoncol.2014.04.004","article-title":"Platelet effects on ovarian cancer","volume":"41","author":"Davis","year":"2014","journal-title":"Sem Oncol"},{"key":"R9-20260812","doi-asserted-by":"crossref","first-page":"610\u201318","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"R10-20260812","doi-asserted-by":"crossref","first-page":"991\u201398","DOI":"10.1160\/TH13-01-0060","article-title":"The physiological and pathophysiological roles of platelet CLEC-2","volume":"109","author":"Langan","year":"2013","journal-title":"Thromb Haemost"},{"key":"R11-20260812","doi-asserted-by":"crossref","first-page":"4387\u201399","DOI":"10.1091\/mbc.e10-06-0489","article-title":"Podoplanin associates with CD44 to promote directional cell migration","volume":"21","author":"Mart\u00edn-Villar","year":"2010","journal-title":"Mol Biol Cell"},{"key":"R12-20260812","doi-asserted-by":"crossref","first-page":"100174","DOI":"10.1016\/j.tru.2024.100174","article-title":"The regulation of cancer-associated thrombosis by podoplanin","volume":"15","author":"Gupta","year":"2024","journal-title":"Thromb Update"},{"key":"R13-20260812","first-page":"54\u201361","article-title":"Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2","volume":"99","author":"Kato","year":"2007","journal-title":"Cancer Sci"},{"key":"R14-20260812","first-page":"100312","article-title":"Pre-treatment thrombocytosis and ovarian cancer survival: a meta-analysis","volume":"22","author":"Pergialiotis","year":"2024","journal-title":"European J Obstet Gynecol Reprod Biol X"},{"key":"R15-20260812","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/cancers11081083","article-title":"The role of intra-tumoral heterogeneity and its clinical relevance in epithelial ovarian cancer recurrence and metastasis","volume":"11","author":"Roberts","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R16-20260812","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00149","article-title":"Harnessing pandemonium: the clinical implications of tumor heterogeneity in ovarian cancer","volume":"5","author":"Blagden","year":"2015","journal-title":"Front Oncol"},{"key":"R17-20260812","doi-asserted-by":"crossref","first-page":"414\u201325","DOI":"10.3109\/03008207.2015.1066780","article-title":"Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity","volume":"56","author":"Albini","year":"2015","journal-title":"Connect Tissue Res"},{"key":"R18-20260812","doi-asserted-by":"crossref","first-page":"498\u2013508","DOI":"10.1634\/stemcells.2008-0868","article-title":"CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature","volume":"27","author":"Kusumbe","year":"2009","journal-title":"Stem Cells"},{"key":"R19-20260812","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/j.celrep.2019.02.032","article-title":"A Pan-ALDH1A inhibitor induces necroptosis in ovarian cancer stem-like cells","volume":"26","author":"Chefetz","year":"2019","journal-title":"Cell Rep"},{"key":"R20-20260812","doi-asserted-by":"crossref","first-page":"383\u201397","DOI":"10.4252\/wjsc.v11.i7.383","article-title":"Presence and role of stem cells in ovarian cancer","volume":"11","author":"Suster","year":"2019","journal-title":"World J Stem Cells"},{"key":"R21-20260812","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.3390\/cells10123429","article-title":"Emerging role of extracellular vesicles and cellular communication in metastasis","volume":"10","author":"Forder","year":"2021","journal-title":"Cells"},{"key":"R22-20260812","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-m\u00f3","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"R23-20260812","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/molecules30030498","article-title":"Extracellular vesicles as mediators and potential targets in combating cancer drug resistance","volume":"30","author":"Zhang","year":"2025","journal-title":"Molecules"},{"key":"R24-20260812","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-04510-8","article-title":"Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion","volume":"13","author":"Tian","year":"2022","journal-title":"Cell Death Dis"},{"key":"R25-20260812","first-page":"104\u201314","article-title":"Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer","volume":"20","author":"Sasano","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R26-20260812","doi-asserted-by":"crossref","first-page":"405\u201310","DOI":"10.1097\/PGP.0b013e3181d3261e","article-title":"Expression of podoplanin in epithelial ovarian carcinomas and its potential as a marker for clear cell adenocarcinoma","volume":"29","author":"Oe","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R27-20260812","doi-asserted-by":"crossref","first-page":"786\u201392","DOI":"10.1080\/09537104.2018.1478401","article-title":"Roles of the CLEC-2\u2013podoplanin interaction in tumor progression","volume":"29","author":"Suzuki-inoue","year":"2018","journal-title":"Platelets"},{"key":"R28-20260812","first-page":"1912\u201318","article-title":"Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin","volume":"134\u2013134","author":"Suzuki-inoue","year":"2019","journal-title":"Blood"},{"key":"R29-20260812","first-page":"370\u201386","article-title":"Podoplanin - a small glycoprotein with many faces","volume":"6","author":"Ugorski","journal-title":"In Am J Cancer Res"},{"key":"R30-20260812","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/cells11030575","article-title":"Roles of podoplanin in malignant progression of tumor","volume":"11","author":"Suzuki","year":"2022","journal-title":"Cells"},{"key":"R31-20260812","doi-asserted-by":"crossref","first-page":"380\u201384","DOI":"10.3109\/09537104.2011.556274","article-title":"The novel platelet activation receptor CLEC-2","volume":"22","author":"Suzuki-Inoue","year":"2011","journal-title":"Platelets"},{"key":"R32-20260812","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/S0049-3848(12)70013-0","article-title":"Platelet CLEC-2 and podoplanin in cancer metastasis","volume":"129","author":"Lowe","year":"2012","journal-title":"Thromb Res"},{"key":"R33-20260812","first-page":"513\u201325","article-title":"C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice","volume":"15","author":"Shirai","year":"2016","journal-title":"J Thromb Haemost"},{"key":"R34-20260812","doi-asserted-by":"crossref","first-page":"576\u201390","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"R35-20260812","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-024-12194-w","article-title":"The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis","volume":"24","author":"Sheng","year":"2024","journal-title":"BMC Cancer"},{"key":"R36-20260812","doi-asserted-by":"crossref","first-page":"1747\u201356","DOI":"10.1182\/blood-2011-09-380709","article-title":"CLEC-2 and syk in the megakaryocytic\/platelet lineage are essential for development","volume":"119","author":"Finney","year":"2012","journal-title":"Blood"},{"key":"R37-20260812","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/ijms20030707","article-title":"Podoplanin in inflammation and cancer","volume":"20","author":"Quintanilla","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R38-20260812","first-page":"4543","article-title":"Tumor cell-derived extracellular vesicles in ovarian cancer: pathophysiological roles and potential as therapeutic targets","volume":"13","author":"Shimada","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R39-20260812","doi-asserted-by":"crossref","first-page":"41\u201351","DOI":"10.1016\/j.semcdb.2015.02.010","article-title":"Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes","volume":"40","author":"Minciacchi","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"R40-20260812","first-page":"1305","article-title":"Lipid rafts and extracellular vesicle biogenesis in cancer","volume":"11","author":"Kawazoe","year":"2021","journal-title":"Biomolecules"},{"key":"R41-20260812","first-page":"85965\u201380","article-title":"Podoplanin-positive extracellular vesicles: a tool to detect peritoneal dissemination of ovarian cancer cells","volume":"8","author":"Hermeter","year":"2017","journal-title":"Oncotarget"},{"key":"R42-20260812","first-page":"3950\u201359","article-title":"Podoplanin: an emerging cancer biomarker and therapeutic target","volume":"112","author":"Krishnan","year":"2021","journal-title":"Cancer Sci"},{"key":"R43-20260812","first-page":"3283\u201393","article-title":"Podoplanin promotes cancer-associated thrombosis and metastasis in ovarian cancer","volume":"4","author":"Kim","year":"2020","journal-title":"Blood Adv"},{"key":"R44-20260812","first-page":"46\u201354","article-title":"Role of podoplanin in cancer-associated thrombosis and tumor progression","volume":"179","author":"Mezouar","year":"2019","journal-title":"Thromb Res"},{"key":"R45-20260812","first-page":"3146\u201356","article-title":"CLEC-2-dependent platelet aggregation is crucial for hematogenous metastasis of murine tumor cells","volume":"128","author":"Shirai","year":"2017","journal-title":"Blood"},{"key":"R46-20260812","first-page":"5945\u201353","article-title":"CLEC-2 signaling regulates cytoskeletal rearrangement and migration of dendritic cells","volume":"119","author":"Kerrigan","year":"2012","journal-title":"Blood"},{"key":"R47-20260812","doi-asserted-by":"crossref","first-page":"661\u201370","DOI":"10.1182\/blood-2010-02-270876","article-title":"Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling","volume":"116","author":"Bertozzi","year":"2010","journal-title":"Blood"},{"key":"R48-20260812","first-page":"1792115","article-title":"Targeting podoplanin in extracellular vesicles reduces thrombosis and metastasis in murine cancer models","volume":"9","author":"Sch\u00f6nfeld","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"R49-20260812","first-page":"3569","article-title":"CD169 mediates the capture of exosomes in lymphoid tissues and permits immune responses","volume":"5","author":"Saunderson","year":"2014","journal-title":"Nat Commun"},{"key":"R50-20260812","first-page":"1\u201312","article-title":"Exosome-mediated thrombin generation in ovarian cancer: a potential diagnostic and therapeutic target","volume":"12","author":"Han","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R51-20260812","first-page":"3429\u201341","article-title":"Therapeutic inhibition of CLEC-2-podoplanin interaction blocks cancer-induced platelet activation and metastasis","volume":"26","author":"Im","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R52-20260812","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fimmu.2012.00283","article-title":"Podoplanin: emerging functions in development, the immune system, and cancer","volume":"3","author":"Astarita","year":"2012","journal-title":"Front Immunol"},{"key":"R53-20260812","first-page":"2319\u201329","article-title":"Podoplanin associates with CD44 to promote directional cell migration","volume":"26","author":"Mart\u00edn-Villar","year":"2015","journal-title":"Mol Biol Cell"},{"key":"R54-20260812","first-page":"2950\u201356","article-title":"Podoplanin: an emerging cancer biomarker and therapeutic target","volume":"110","author":"Krishnan","year":"2019","journal-title":"Cancer Sci"},{"key":"R55-20260812","first-page":"63\u201367","article-title":"CLEC-2\/podoplanin in tumor metastasis","volume":"67","author":"Suzuki-Inoue","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"R56-20260812","first-page":"789","article-title":"Ovarian cancer-associated thrombosis: pathophysiology and emerging therapeutic targets","volume":"13","author":"Soliman","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R57-20260812","first-page":"2459","article-title":"Targeting platelet interaction with tumor cells using anti-podoplanin antibodies reduces tumor metastasis in vivo","volume":"22","author":"Choi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R58-20260812","first-page":"55\u201365","article-title":"Extracellular vesicles in ovarian cancer: mediators of metastasis and promising biomarkers","volume":"505","author":"Wang","year":"2021","journal-title":"Cancer Lett"},{"key":"R59-20260812","first-page":"33","article-title":"Tumor-derived extracellular vesicles influence the immune system in head and neck cancer","volume":"6","author":"Theodoraki","year":"2020","journal-title":"J Cancer Metastasis Treat"},{"key":"R60-20260812","doi-asserted-by":"crossref","first-page":"1425\u201335","DOI":"10.1634\/stemcells.2007-1076","article-title":"Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells","volume":"26","author":"Kong","year":"2008","journal-title":"Stem Cells"},{"key":"R61-20260812","article-title":"Platelets in the tumor microenvironment and their biological effects on cancer hallmarks","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol"},{"key":"R63-20260812","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcb.2015.07.012","article-title":"Epithelial\u2013mesenchymal plasticity: a central regulator of cancer progression","author":"Ye","year":"2015","journal-title":"Trends Cell Biol"},{"key":"R64-20260812","doi-asserted-by":"crossref","first-page":"100773","DOI":"10.1016\/j.tranon.2020.100773","article-title":"Epithelial-mesenchymal transition in cancer: a historical overview","volume":"13","author":"Ribatti","year":"2020","journal-title":"Transl Oncol"},{"key":"R65-20260812","doi-asserted-by":"crossref","first-page":"5846\u201359","DOI":"10.18632\/oncotarget.3462","article-title":"CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition","volume":"6","author":"Long","year":"2015","journal-title":"Oncotarget"},{"key":"R66-20260812","doi-asserted-by":"crossref","first-page":"5\u201316","DOI":"10.1002\/cam4.4","article-title":"Overexpression of snail induces epithelial\u2013mesenchymal transition and a cancer stem cell\u2013like phenotype in human colorectal cancer cells","volume":"1","author":"Fan","year":"2012","journal-title":"Cancer Med"},{"key":"R67-20260812","doi-asserted-by":"crossref","first-page":"e12445","DOI":"10.1371\/journal.pone.0012445","article-title":"Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells","volume":"5","author":"Kong","year":"2010","journal-title":"PLoS One"},{"key":"R68-20260812","doi-asserted-by":"crossref","first-page":"340\u201351","DOI":"10.1093\/jnci\/djp535","article-title":"Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma","volume":"102","author":"Rasheed","year":"2010","journal-title":"JNCI J Natl Cancer Inst"},{"key":"R69-20260812","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aau8544","article-title":"Chronic TGF-\u03b2 exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition","volume":"12","author":"Katsuno","year":"2019","journal-title":"Sci Signal"},{"key":"R70-20260812","article-title":"An overview of agents and treatments for PDGFRA-mutated gastrointestinal stromal tumors","volume":"12","author":"Sun","year":"2022","journal-title":"Front Oncol"},{"key":"R71-20260812","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.3390\/ijms21218169","article-title":"Platelets, thrombocytosis, and ovarian cancer prognosis: surveying the landscape of literature","volume":"21","author":"Hufnagel","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R72-20260812","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2018.00013","article-title":"Platelet microparticles and mIRNA transfer in cancer progression: many targets, modes of action, and effects across cancer stages","volume":"5","author":"Lazar","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"R73-20260812","article-title":"Cancer stem cells: advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"R74-20260812","doi-asserted-by":"crossref","first-page":"55771\u201388","DOI":"10.18632\/oncotarget.9908","article-title":"Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer","volume":"7","author":"Deng","year":"2016","journal-title":"Oncotarget"},{"key":"R76-20260812","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.3390\/ijms25073843","article-title":"A stem-like patient-derived ovarian cancer model of platinum resistance reveals dissociation of stemness and resistance","volume":"25","author":"Suzuki","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R77-20260812","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02280-3","article-title":"Understanding gold nanoparticles and their attributes in ovarian cancer therapy","volume":"24","author":"Aggarwal","year":"2025","journal-title":"Mol Cancer"},{"key":"R78-20260812","doi-asserted-by":"crossref","first-page":"42733\u201348","DOI":"10.18632\/oncotarget.5811","article-title":"Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis","volume":"6","author":"Chang","year":"2015","journal-title":"Oncotarget"},{"key":"R79-20260812","article-title":"Podoplanin: a potential therapeutic target for thrombotic diseases","volume":"14","author":"Huang","year":"2023","journal-title":"Front Neurol"},{"key":"R80-20260812","doi-asserted-by":"crossref","first-page":"10572","DOI":"10.3390\/ijms221910572","article-title":"Extracellular vesicles and cancer stem cells in tumor progression: new therapeutic perspectives","volume":"22","author":"Scioli","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R81-20260812","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"R83-20260812","doi-asserted-by":"crossref","first-page":"1392\u2013406","DOI":"10.1093\/cvr\/cvaf100","article-title":"Platelets and inflammation - insights from platelet non-coding RNA content and release in the bruneck study and the PACMAN-AMI trial","volume":"121","author":"Gutmann","year":"2025","journal-title":"Cardiovasc Res"},{"key":"R84-20260812","doi-asserted-by":"crossref","first-page":"904\u201314","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol Cell"},{"key":"R85-20260812","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02265-2","article-title":"Cancer stem cells and niches: challenges in immunotherapy resistance","volume":"24","author":"Pan","year":"2025","journal-title":"Mol Cancer"},{"key":"R86-20260812","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.879351","article-title":"Insights into platelet-derived MicroRNAs in cardiovascular and oncologic diseases: potential predictor and therapeutic target","volume":"9","author":"Leng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R87-20260812","first-page":"219","article-title":"Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance","volume":"10","author":"Song","year":"2025","journal-title":"PubMed"},{"key":"R88-20260812","first-page":"529\u201345","article-title":"miRNAs and radiotherapy response in prostate cancer","volume":"9","author":"Konoshenko","year":"2020","journal-title":"Andrology"},{"key":"R89-20260812","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0831-z","article-title":"Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment","volume":"17","author":"Sun","year":"2018","journal-title":"Mol Cancer"},{"key":"R90-20260812","first-page":"36\u201342","article-title":"Recent advances in extracellular vesicles enriched with non-coding RNAs related to cancers","volume":"5","author":"Yang","year":"2017","journal-title":"Genes Diseases"},{"key":"R91-20260812","doi-asserted-by":"crossref","first-page":"567\u201380","DOI":"10.1182\/blood-2016-11-751099","article-title":"Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth","volume":"130","author":"Michael","year":"2017","journal-title":"Blood"},{"key":"R92-20260812","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz1580","article-title":"Platelet P-selectin initiates cross-presentation and dendritic cell differentiation in blood monocytes","volume":"6","author":"Han","year":"2020","journal-title":"Sci Adv"},{"key":"R93-20260812","doi-asserted-by":"crossref","first-page":"e0243928","DOI":"10.1371\/journal.pone.0243928","article-title":"Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: results from ExPeCT, a randomised controlled trial","volume":"15","author":"Brady","year":"2020","journal-title":"PLoS ONE"},{"key":"R94-20260812","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.3390\/cancers13215272","article-title":"Circulating tumor cell clusters are cloaked with platelets and correlate with poor prognosis in unresectable pancreatic cancer","volume":"13","author":"Lim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R95-20260812","doi-asserted-by":"crossref","first-page":"100\u201312","DOI":"10.1016\/j.ebiom.2018.11.004","article-title":"Exosomal miRNA confers chemo resistance via targeting Cav1\/p-gp\/M2-type macrophage axis in ovarian cancer","volume":"38","author":"Kanlikilicer","year":"2018","journal-title":"eBioMedicine"},{"key":"R96-20260812","doi-asserted-by":"crossref","first-page":"1935\u201348","DOI":"10.1002\/1878-0261.12371","article-title":"Exosomal microRNAs as tumor markers in epithelial ovarian cancer","volume":"12","author":"Pan","year":"2018","journal-title":"Mol Oncol"},{"key":"R97-20260812","doi-asserted-by":"crossref","first-page":"145\u201356","DOI":"10.1038\/nrclinonc.2014.5","article-title":"Clinical relevance of circulating cell-free microRNAs in cancer","volume":"11","author":"Schwarzenbach","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"R98-20260812","doi-asserted-by":"crossref","first-page":"1958\u201367","DOI":"10.7150\/jca.30231","article-title":"Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas","volume":"10","author":"Kim","year":"2019","journal-title":"J Cancer"},{"key":"R99-20260812","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12943-022-01703-9","article-title":"Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis","volume":"22","author":"Mo","year":"2023","journal-title":"Mol Cancer"},{"key":"R100-20260812","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1186\/s12885-018-4974-5","article-title":"Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells","volume":"18","author":"Yoshimura","year":"2018","journal-title":"BMC Cancer"},{"key":"R101-20260812","first-page":"345\u201355","article-title":"Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review)","volume":"50","author":"Wang","year":"2016","journal-title":"Int J Oncol"},{"key":"R102-20260812","doi-asserted-by":"crossref","first-page":"1\u20139","DOI":"10.1016\/j.bbrc.2023.06.068","article-title":"LncRNA ASB16-AS1 accelerates cellular process and chemoresistance of ovarian cancer cells by regulating GOLM1 expression via targeting miR-3918","volume":"675","author":"Fan","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"R103-20260812","doi-asserted-by":"crossref","first-page":"1095\u2013104","DOI":"10.1007\/s13258-021-01138-4","article-title":"LncRNA SNHG20 promotes cell proliferation and invasion by suppressing miR-217 in ovarian cancer","volume":"43","author":"Xing","year":"2021","journal-title":"Genes Genomics"},{"key":"R104-20260812","first-page":"1098\u2013110","article-title":"lncRNA AC005224.4\/miR-140-3p\/SNAI2 regulating axis facilitates the invasion and metastasis of ovarian cancer through epithelial-mesenchymal transition","volume":"136","author":"Xiong","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"R105-20260812","doi-asserted-by":"crossref","first-page":"169\u201379","DOI":"10.32604\/or.2023.027815","article-title":"LncRNA CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote malignant phenotypes in ovarian cancer cells","volume":"31","author":"Jin","year":"2023","journal-title":"Oncol Res"},{"key":"R106-20260812","first-page":"8230\u201338","article-title":"LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN","volume":"23","author":"Kong","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R107-20260812","first-page":"2224\u201335","article-title":"LncRNA PART1 Stimulates the Development of Ovarian Cancer by Up-regulating RACGAP1 and RRM2","volume":"29","author":"Li","year":"2022","journal-title":"Reprod. Sci (Thousand oaks Calif)"},{"key":"R108-20260812","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12935-022-02602-1","article-title":"Emerging role of circular RNAs in the pathogenesis of ovarian cancer","volume":"22","author":"Ghafouri-fard","year":"2022","journal-title":"Cancer Cell Int"},{"key":"R109-20260812","first-page":"5281\u201391","article-title":"CircRNA_MYLK promotes malignant progression of ovarian cancer through regulating microRNA-652","volume":"24","author":"Zhao","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R110-20260812","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-018-0869-y","article-title":"Role of hypoxia-induced exosomes in tumor biology","volume":"17","author":"Shao","year":"2018","journal-title":"Mol Cancer"},{"key":"R111-20260812","doi-asserted-by":"crossref","first-page":"765458","DOI":"10.3389\/fonc.2021.765458","article-title":"Emerging functions and clinical applications of exosomal ncRNAs in ovarian cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"R112-20260812","doi-asserted-by":"crossref","first-page":"113609","DOI":"10.1016\/j.biopha.2022.113609","article-title":"LncRNA-miRNA axis in tumor progression and therapy response: an emphasis on molecular interactions and therapeutic interventions","volume":"154","author":"Entezari","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R113-20260812","doi-asserted-by":"crossref","first-page":"1332528","DOI":"10.3389\/fonc.2024.1332528","article-title":"The roles of long non-coding RNAs in ovarian cancer: from functions to therapeutic implications","volume":"14","author":"Hu","year":"2024","journal-title":"Front Oncol"},{"key":"R114-20260812","doi-asserted-by":"crossref","first-page":"99\u2013109","DOI":"10.1016\/j.semcancer.2021.08.005","article-title":"Platinum-resistant ovarian cancer: from drug resistance to liquid biopsy biomarkers","volume":"77","author":"Khan","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"R115-20260812","doi-asserted-by":"crossref","first-page":"36815\u201324","DOI":"10.18632\/oncotarget.5766","article-title":"Plasma miR-200b in ovarian carcinoma: distinct pre\/post-treatment variation and progression-free survival prediction","volume":"6","author":"Kapetanakis","year":"2015","journal-title":"Oncotarget"},{"key":"R116-20260812","doi-asserted-by":"crossref","first-page":"11150","DOI":"10.1038\/ncomms11150","article-title":"Exosomal miR21 confers paclitaxel resistance in ovarian cancer via APAF1","volume":"7","author":"Au Yeung","year":"2016","journal-title":"Nat Commun"},{"key":"R117-20260812","doi-asserted-by":"crossref","first-page":"1174\u201396","DOI":"10.1039\/C8LC00100F","article-title":"Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances","volume":"18","author":"Gorgannezhad","year":"2018","journal-title":"Lab Chip"},{"key":"R118-20260812","doi-asserted-by":"crossref","first-page":"688\u2013701","DOI":"10.1038\/nrurol.2014.301","article-title":"The emerging role of extracellular vesicles as biomarkers for urogenital cancers","volume":"11","author":"Nawaz","year":"2014","journal-title":"Nat Rev Urol"},{"key":"R119-20260812","doi-asserted-by":"crossref","first-page":"148\u201356","DOI":"10.1016\/j.addr.2016.02.006","article-title":"Extracellular vesicles for drug delivery: challenges and opportunities","volume":"106","author":"Vader","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"R120-20260812","first-page":"627\u201334","article-title":"Exosome-mediated delivery of miR-21 inhibitors suppresses tumor growth in ovarian cancer mouse models","volume":"17","author":"Liu","year":"2019","journal-title":"Mol Ther Nucl Acids"},{"key":"R121-20260812","doi-asserted-by":"crossref","first-page":"2495\u2013505","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N Engl J Med"},{"key":"R122-20260812","first-page":"1802\u201310","article-title":"Platelets promote tumor growth and metastasis via direct interaction between podoplanin and CLEC-2","volume":"108","author":"Takagi","year":"2017","journal-title":"Cancer Sci"},{"key":"R123-20260812","doi-asserted-by":"crossref","first-page":"489\u201394","DOI":"10.1038\/nature14410","article-title":"Whole-genome characterization of chemoresistant ovarian cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"R124-20260812","first-page":"880\u201389","article-title":"Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA","volume":"58","author":"An","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"R125-20260812","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018)","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"R126-20260812","doi-asserted-by":"crossref","first-page":"965\u201383","DOI":"10.1016\/j.ccell.2018.03.002","article-title":"The platelet lifeline to cancer: challenges and opportunities","volume":"33","author":"Haemmerle","year":"2018","journal-title":"Cancer Cell"},{"key":"R127-20260812","first-page":"503\u201311","article-title":"Combination strategies with PARP inhibitors in ovarian cancer","volume":"162","author":"O\u2019connell","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R128-20260812","doi-asserted-by":"crossref","first-page":"1\u201310","DOI":"10.1016\/j.canlet.2022.01.012","article-title":"Artificial intelligence in cancer diagnosis and prognosis: opportunities and challenges","volume":"524","author":"Zhang","year":"2022","journal-title":"Cancer Lett"},{"key":"R129-20260812","doi-asserted-by":"crossref","DOI":"10.70389\/PJS.100082","article-title":"Transparency in the reporting of Artificial Intelligence \u2013 the TITAN guideline","author":"Agha","year":"2025","journal-title":"Prem J Sci"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:39:41Z","timestamp":1786545581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000005293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":126,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000005293","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"2025-10-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}